A feasibility study of lamivudine/zidovudine (3TC/ZDV) plus efavirenz (EFV) as initial therapy of HIV-1 infected patients in a rural area of china

Trial Profile

A feasibility study of lamivudine/zidovudine (3TC/ZDV) plus efavirenz (EFV) as initial therapy of HIV-1 infected patients in a rural area of china

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 13 Jul 2007

At a glance

  • Drugs Efavirenz (Primary) ; Lamivudine/zidovudine (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2007 Status changed from in progress to completed
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top